Call for Expression of Interest

Open Call for Expression of Interest: Experts to Serve on the Technical Committees of the African Medicines Agency

Date of Issue: 11 May 2026
Closing Date for Applications: 18 June 2026

A. Background

The African Medicines Agency, established under the AMA Treaty adopted by the African Union, is a specialised continental regulatory agency. The main objective of AMA is to enhance the capacity of State Parties and Regional Economic Communities (RECs) to regulate medical products in order to improve access to quality, safe, and efficacious medical products across the continent.

In accordance with Article 20 of the AMA Treaty, the Agency is mandated to establish permanent or ad hoc technical committees to provide technical guidance on specific areas of regulatory expertise. In line with Article 21 of the AMA Treaty, the technical committees shall be responsible for carrying out scientific assessments and conducting scientific reviews of dossiers, including quality aspects and clinical trial applications; inspection of manufacturing facilities; and providing scientific opinions to facilitate the proper functioning of AMA.

AMA Technical Committees provide scientific, technical, and regulatory advice to support the work of the Agency and contribute to strengthening regulatory convergence, scientific excellence, and access to safe, effective, and quality-assured medical products across Africa.

In accordance with the AMA Treaty and the operationalisation of AMA’s technical functions, the Agency invites Expressions of Interest (EOI) from suitably qualified experts from African Union Member States, particularly State Parties to the AMA Treaty, to serve on AMA Technical Committees (TCs).

B. Technical Committees

AMA seeks experts with demonstrated experience in one or more areas relevant to the regulation of medical products, including but not limited to:

  1. Evaluation of Medicines, Vaccines, and Biologicals
  2. Regulatory Inspections, including Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) inspections
  3. Medical Devices, Diagnostics, and Emerging Technologies Assessment
  4. Clinical Trials Oversight and Good Clinical Practice
  5. Market Intelligence and Control
  6. Vigilance
  7. Innovation and Emerging Technologies
Deadline

18 June 2026

Bid Number

N/A